Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of written informed consent for study participation before initiation of any study related procedures, signed by the patient's legal guardian
Female and/or male, aged between 18 and 60 years (inclusive)
Is hospitalised in a psychiatric unit with an acute episode of schizophrenia defined by CCMD-3 criteria as one of the following: \[20.1\] paranoid schizophrenia, \[20.2\] hebephrenic schizophrenia, \[20.3\] catatonic schizophrenia, \[20.5\] undifferentiated schizophrenia
You may not be if
CCMD-3 diagnosis of mental retardation
Psychosis judged to be the direct physiological effect of an abused medication or substance
Clareo Health | Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic
